Not all sarcomas developed in irradiated tissue are necessarily radiation-induced - Spectrum of disease and treatment characteristics

Critical Reviews in Oncology/Hematology

Volumn 83, Issue 3, 2012, Pages 393-406

  Thariat, Juliette ^a   Italiano, Antoine ^b   Collin, Fabrice ^c   Iannessi, Antoine ^d   Marcy, Pierre Yves ^d   Lacout, Alexis ^e   Birtwisle Peyrottes, Isabelle ^d   Thyss, Antoine ^d   Lagrange, Jean Léon ^f  

^a CENTRE DE BIOCHIMIE   (France)

^b INSTITUT BERGONIÉ   (France)

^c UMR 152 IRD Universite Paul Sabatier   (France)

^d CENTRE ANTOINE LACASSAGNE   (France)

^e Centre d'Imagerie   (France)

^f UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Radiation induced sarcoma; Radiogenic; Response; Sarcoma in irradiated tissue; Second cancer; Signature

Indexed keywords

ALKYLATING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CYCLOPHOSPHAMIDE; DENOSUMAB; DOXORUBICIN; IFOSFAMIDE;

AGE; ANGIOSARCOMA; BENIGN TUMOR; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE FREE SURVIVAL; GENE OVEREXPRESSION; GENETIC DIFFERENCE; GENETIC PREDISPOSITION; GIANT CELL TUMOR; HEAD AND NECK TUMOR; HUMAN; INTENSITY MODULATED RADIATION THERAPY; ION THERAPY; LYMPHOMA; MALIGNANT FIBROUS HISTIOCYTOMA; ONCOGENE C MYC; OSTEOSARCOMA; OVERALL SURVIVAL; OXIDATIVE STRESS; PROSTATE TUMOR; PROTON THERAPY; RADIATION CARCINOGENESIS; RADIATION INDUCED NEOPLASM; RECURRENCE FREE SURVIVAL; REVIEW; RISK FACTOR; SARCOMA; SARCOMA IN IRRADIATED TISSUE; SECOND CANCER; SOFT TISSUE SARCOMA; SURVIVAL RATE; TESTIS TUMOR; TRANSCRIPTOMICS; TUMOR LOCALIZATION;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RISK FACTORS; SARCOMA;

EID: 84864933958     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2011.11.004     Document Type: Review

References (86)

1. de Gonzalez A.B., Curtis R.E., Kry S.F., et al. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol 2011, 12(April (4)):353-360.
2. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, (July).
3. Patel S.R Radiation-induced sarcoma. Curr Treat Options Oncol 2000, 1(August (3)):258-261.
4. Cahan W.G., Woodard H.Q., Higinbotham N.L., Stewart F.W., Coley B.L. Sarcoma arising in irradiated bone: report of eleven cases. 1948. Cancer 1998, 82(January (1)):8-34.
5. Arlen M., Higinbotham N.L., Huvos A.G., Marcove R.C., Miller T., Shah I.C. Radiation-induced sarcoma of bone. Cancer 1971, 28(November (5)):1087-1099.
6. Karlssoni P., Holmberg E., Samuelsson A., Johansson K.A., Wallgren A. Soft tissue sarcoma after treatment for breast cancer-a Swedish population-based study. Eur J Cancer 1998, 34(December (13)):2068-2075.
7. Mark R.J., Poen J., Tran L.M., Fu Y.S., Selch M.T., Parker R.G. Postirradiation sarcomas. A single-institution study and review of the literature. Cancer 1994, 73(May (10)):2653-2662.
8. Riad S., Biau D., Holt G.E., et al. The clinical and functional outcome for patients with radiation-induced soft tissue sarcoma. Cancer 2011, (October).
9. Gladdy R.A., Qin L.X., Moraco N., et al. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas?. J Clin Oncol 2010, 28(April (12)):2064-2069.
10. Brady M.S., Gaynor J.J., Brennan M.F. Radiation-associated sarcoma of bone and soft tissue. Arch Surg 1992, 127(December (12)):1379-1385.
11. Murray E.M., Werner D., Greeff E.A., Taylor D.A. Postradiation sarcomas: 20 cases and a literature review. Int J Radiat Oncol Biol Phys 1999, 45(November (4)):951-961.
12. Menu-Branthomme A., Rubino C., Shamsaldin A., et al. Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood. Int J Cancer 2004, 110(May (1)):87-93.
13. Lagrange J.L., Ramaioli A., Chateau M.C., et al. Sarcoma after radiation therapy: retrospective multiinstitutional study of 80 histologically confirmed cases. Radiation Therapist and Pathologist Groups of the Federation Nationale des Centres de Lutte Contre le Cancer. Radiology 2000, 216(July (1)):197-205.
14. Virtanen A., Pukkala E., Auvinen A. Incidence of bone and soft tissue sarcoma after radiotherapy: a cohort study of 295,712 Finnish cancer patients. Int J Cancer 2006, 118(February (4)):1017-1021.
15. Li F.P., Cassady J.R., Jaffe N. Risk of second tumors in survivors of childhood cancer. Cancer 1975, 35(April (4)):1230-1235.
16. Bacci G., Longhi A., Barbieri E., et al. Second malignancy in 597 patients with Ewing sarcoma of bone treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999. J Pediatr Hematol Oncol 2005, 27(October (10)):517-520.
17. Tubiana M., Feinendegen L.E., Yang C., Kaminski J.M. The linear no-threshold relationship is inconsistent with radiation biologic and experimental data. Radiology 2009, 251(April (1)):13-22.
18. Yap J., Chuba P.J., Thomas R., et al. Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys 2002, 52(April (5)):1231-1237.
19. Tukenova M., Diallo I., Hawkins M., et al. Long-term mortality from second malignant neoplasms in 5-year survivors of solid childhood tumors: temporal pattern of risk according to type of treatment. Cancer Epidemiol Biomarkers Prev 2010, 19(March (3)):707-715.
20. Wiklund T.A., Blomqvist C.P., Raty J., Elomaa I., Rissanen P., Miettinen M. Postirradiation sarcoma. Analysis of a nationwide cancer registry material. Cancer 1991, 68(August (3)):524-531.
21. Kuttesch J.F., Wexler L.H., Marcus R.B., et al. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol 1996, 14(October (10)):2818-2825.
22. Hall E.J., Henry S. Kaplan Distinguished Scientist Award 2003. The crooked shall be made straight; dose-response relationships for carcinogenesis. Int J Radiat Biol 2004, 80(May (5)):327-337.
23. Suit H., Goldberg S., Niemierko A., et al. Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res 2007, 167(January (1)):12-42.
24. MacDougall R.H., Kerr G.R., Duncan W. Incidence of sarcoma in patients treated with fast neutrons. Int J Radiat Oncol Biol Phys 2006, 66(November (3)):842-844.
25. Bartkowiak D., Humble N., Suhr P., et al. Second cancer after radiotherapy, 1981-2007. Radiother Oncol 2011, (October).
26. Singh S., Kloss F.R., Brunauer R., et al. Mesenchymal stem cells show radioresistance in vivo. J Cell Mol Med 2011, (July).
27. Gonin-Laurent N., Hadj-Hamou N.S., Vogt N., et al. RB1 and TP53 pathways in radiation-induced sarcomas. Oncogene 2007, 26(September (41)):6106-6112.
28. Tarkkanen M., Wiklund T.A., Virolainen M.J., et al. Comparative genomic hybridization of postirradiation sarcomas. Cancer 2001, 92(October (7)):1992-1998.
29. Young R.J., Brown N.J., Reed M.W., Hughes D., Woll P.J. Angiosarcoma. Lancet Oncol 2010, (May).
30. Manner J., Radlwimmer B., Hohenberger P., et al. MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol 2010, 176(January (1)):34-39.
31. Hadj-Hamou N.S., Ugolin N., Ory C., et al. A transcriptome signature distinguished sporadic from post-radiotherapy radiation-induced sarcomas. Carcinogenesis 2011, (April).
32. Zhang B., Ma J.X. SERPINA3K prevents oxidative stress induced necrotic cell death by inhibiting calcium overload. PLoS One 2008, 3(12):e4077.
33. Berrington de Gonzalez A., Curtis R.E., Gilbert E., et al. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer 2010, 102(January (1)):220-226.
34. Kirova Y.M., Vilcoq J.R., Asselain B., Sastre-Garau X., Fourquet A. Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review. Cancer 2005, 104(August (4)):856-863.
35. Hancock S.L., Hoppe R.T. Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin Radiat Oncol 1996, 6(July (3)):225-242.
36. Mauch P.M., Kalish L.A., Marcus K.C., et al. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood 1996, 87(May (9)):3625-3632.
37. Swerdlow A.J., Douglas A.J., Hudson G.V., Hudson B.V., Bennett M.H., MacLennan K.A. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. Br Med J 1992, 304(May (6835)):1137-1143.
38. Bertoni F., Bacchini P., Staals E.L. Malignancy in giant cell tumor of bone. Cancer 2003, 97(May (10)):2520-2529.
39. Ruka W., Rutkowski P., Morysinski T., et al. The megavoltage radiation therapy in treatment of patients with advanced or difficult giant cell tumors of bone. Int J Radiat Oncol Biol Phys 2009, (December).
40. Caudell J.J., Ballo M.T., Zagars G.K., et al. Radiotherapy in the management of giant cell tumor of bone. Int J Radiat Oncol Biol Phys 2003, 57(September (1)):158-165.
41. Tse L.F., Wong K.C., Kumta S.M., Huang L., Chow T.C., Griffith J.F. Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study. Bone 2008, 42(January (1)):68-73.
42. Thomas D., Henshaw R., Skubitz K., et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 2010, 11(March (3)):275-280.
43. Jacobsen G.K., Mellemgaard A., Engelholm S.A., Moller H. Increased incidence of sarcoma in patients treated for testicular seminoma. Eur J Cancer 1993, 29A(5):664-668.
44. Muller A.C., Ganswindt U., Bamberg M., Belka C. Risk of second malignancies after prostate irradiation?. Strahlenther Onkol 2007, 183(November (11)):605-609.
45. Huang J., Kestin L.L., Ye H., Wallace M., Martinez A.A., Vicini F.A. Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer. Radiother Oncol 2011, 98(January (1)):81-86.
46. Brada M., Ford D., Ashley S., et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. Br Med J 1992, 304(May (6838)):1343-1346.
47. Berkmann S., Tolnay M., Hanggi D., Ghaffari A., Gratzl O. Sarcoma of the sella after radiotherapy for pituitary adenoma. Acta Neurochir (Wien) 2010, 152(May):1725-1735.
48. Tucker M.A., D'Angio G.J., Boice J.D., et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 1987, 317(September (10)):588-593.
49. de Vathaire F., Schweisguth O., Rodary C., et al. Long-term risk of second malignant neoplasm after a cancer in childhood. Br J Cancer 1989, 59(March (3)):448-452.
50. Koshy M., Paulino A.C., Mai W.Y., Teh B.S. Radiation-induced osteosarcomas in the pediatric population. Int J Radiat Oncol Biol Phys 2005, 63(November (4)):1169-1174.
51. Newton W.A., Meadows A.T., Shimada H., Bunin G.R., Vawter G.F. Bone sarcomas as second malignant neoplasms following childhood cancer. Cancer 1991, 67(January (1)):193-201.
52. Liberman L., Dershaw D.D., Kaufman R.J., Rosen P.P. Angiosarcoma of the breast. Radiology 1992, 183(June (3)):649-654.
53. Marchal C., Weber B., de Lafontan B., et al. Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive Cancer Centers. Int J Radiat Oncol Biol Phys 1999, 44(April (1)):113-119.
54. Shao Z., He Y., Wang L., Hu H., Shi H. Computed tomography findings in radiation-induced osteosarcoma of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010, 109(March (3)):e88-e94.
55. Makimoto Y., Yamamoto S., Takano H., et al. Imaging findings of radiation-induced sarcoma of the head and neck. Br J Radiol 2007, 80(October (958)):790-797.
56. Holt G.E., Thomson A.B., Griffin A.M., et al. Multifocality and multifocal postradiation sarcomas. Clin Orthop Relat Res 2006, 450(September):67-75.
57. Shapeero L.G. An algorithm for soft tissue tumors: current perspectives. Semin Musculoskelet Radiol 1999, 3(2):206-212.
58. Panicek D.M., Schwartz L.H., Heelan R.T., Caravelli J.F. Non-neoplastic causes of high signal intensity at T2-weighted MR imaging after treatment for musculoskeletal neoplasm. Skeletal Radiol 1995, 24(April (3)):185-190.
59. Bjerkehagen B., Smeland S., Walberg L., et al. Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital. Acta Oncol 2008, 47(8):1475-1482.
60. Vanel D., Shapeero L.G., De Baere T., et al. MR imaging in the follow-up of malignant and aggressive soft-tissue tumors: results of 511 examinations. Radiology 1994, 190(January (1)):263-268.
61. Shapeero L.G., Vanel D., Verstraete K.L., Bloem J.L. Fast magnetic resonance imaging with contrast for soft tissue sarcoma viability. Clin Orthop Relat Res 2002, 397(April):212-227.
62. Vanel D., Shapeero L.G., Tardivon A., Western A., Guinebretiere J.M. Dynamic contrast-enhanced MRI with subtraction of aggressive soft tissue tumors after resection. Skeletal Radiol 1998, 27(September (9)):505-510.
63. Pitcher M.E., Davidson T.I., Fisher C., Thomas J.M. Post irradiation sarcoma of soft tissue and bone. Eur J Surg Oncol 1994, 20(February (1)):53-56.
64. Robinson E., Neugut A.I., Wylie P. Clinical aspects of postirradiation sarcomas. J Natl Cancer Inst 1988, 80(April (4)):233-240.
65. Patel S.G., See A.C., Williamson P.A., Archer D.J., Evans P.H. Radiation induced sarcoma of the head and neck. Head Neck 1999, 21(July (4)):346-354.
66. Cha C., Antonescu C.R., Quan M.L., Maru S., Brennan M.F. Long-term results with resection of radiation-induced soft tissue sarcomas. Ann Surg 2004, 239(June (6)):903-909. discussion 9-10.
67. Billings S.D., McKenney J.K., Folpe A.L., Hardacre M.C., Weiss S.W. Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases. Am J Surg Pathol 2004, 28(June (6)):781-788.
68. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet 1997, 350(December (9092)):1647-1654.
69. Pervaiz N., Colterjohn N., Farrokhyar F., Tozer R., Figueredo A., Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 2008, 113(August (3)):573-581.
70. Italiano A., Laurand A., Laroche A., et al. ERCC5/XPG ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma. Cancer 2010, (February).
71. Gortzak E., Azzarelli A., Buesa J., et al. A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. Eur J Cancer 2001, 37(June (9)):1096-1103.
72. des Guetz G., Chapelier A., Mosseri V., Dorval T., Asselain B., Pouillart P. Postirradiation sarcoma: clinicopathologic features and role of chemotherapy in the treatment strategy. Sarcoma 2009, 2009:764379.
73. Mir O., Domont J., Cioffi A., et al. Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcoma. Eur J Cancer 2011, 47(March (4)):515-519.
74. Italiano A., Cioffi A., Penel N., Giaj Levra M., Delcambre C., Kalbacher E., et al. Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas. Cancer 2011, 10.1002/cncr.26599.
75. Maclean K.H., Keller U.B., Rodriguez-Galindo C., Nilsson J.A., Cleveland J.L. c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL. Mol Cell Biol 2003, 23(October (20)):7256-7270.
76. Evan G.I., Wyllie A.H., Gilbert C.S., et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992, 69(April (1)):119-128.
77. Albihn A., Loven J., Ohlsson J., Osorio L.M., Henriksson M. c-Myc-dependent etoposide-induced apoptosis involves activation of Bax and caspases, and PKCdelta signaling. J Cell Biochem 2006, 98(August (6)):1597-1614.
78. Adachi S., Obaya A.J., Han Z., Ramos-Desimone N., Wyche J.H., Sedivy J.M. c-Myc is necessary for DNA damage-induced apoptosis in the G(2) phase of the cell cycle. Mol Cell Biol 2001, 21(August (15)):4929-4937.
79. Grassilli E., Ballabeni A., Maellaro E., Del Bello B., Helin K. Loss of MYC confers resistance to doxorubicin-induced apoptosis by preventing the activation of multiple serine protease- and caspase-mediated pathways. J Biol Chem 2004, 279(May (20)):21318-21326.
80. Kirova Y.M., Feuilhade F., Calitchi E., Otmezguine Y., Belembaogo E., Le Bourgeois J.P. Radiation-induced sarcoma after breast cancer Apropos of 8 cases and review of the literature. Cancer Radiother 1998, 2(July-August (4)):381-386.
81. Torres M.A., Ballo M.T., Butler C.E., et al. Management of locally recurrent soft-tissue sarcoma after prior surgery and radiation therapy. Int J Radiat Oncol Biol Phys 2007, 67(March (4)):1124-1129.
82. Indelicato D.J., Meadows K., Gibbs C.P., Morris C.G., Scarborough M.T., Zlotecki R.A. Effectiveness and morbidity associated with reirradiation in conservative salvage management of recurrent soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 2009, 73(January (1)):267-272.
83. Meadows A.T., Baum E., Fossati-Bellani F., et al. Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol 1985, 3(April (4)):532-538.
84. Inoue Y.Z., Frassica F.J., Sim F.H., Unni K.K., Petersen I.A., McLeod R.A. Clinicopathologic features and treatment of postirradiation sarcoma of bone and soft tissue. J Surg Oncol 2000, 75(September (1)):42-50.
85. Franco Gutierrez V., Llorente Pendas J.L., Coca Pelaz A., Cabanillas Farpon R., Suarez Nieto C. Radiation-induced sarcomas of the head and neck. J Craniofac Surg 2008, 19(September (5)):1287-1291.
86. Pellitteri P.K., Ferlito A., Bradley P.J., Shaha A.R., Rinaldo A. Management of sarcomas of the head and neck in adults. Oral Oncol 2003, 39(January (1)):2-12.